Published in J Korean Med Sci on February 17, 2010
Insights into restrictive cardiomyopathy from clinical and animal studies. J Geriatr Cardiol (2011) 0.93
Activated protein C protects myocardium via activation of anti-apoptotic pathways of survival in ischemia-reperfused rat heart. J Korean Med Sci (2010) 0.85
The Protective Effect of Epigallocatechin-3 Gallate on Ischemia/Reperfusion Injury in Isolated Rat Hearts: An ex vivo Approach. Korean J Physiol Pharmacol (2011) 0.83
Morphine-induced postconditioning modulates mitochondrial permeability transition pore opening via delta-1 opioid receptors activation in isolated rat hearts. Korean J Anesthesiol (2011) 0.80
Protective effect of sauchinone against regional myocardial ischemia/reperfusion injury: inhibition of p38 MAPK and JNK death signaling pathways. J Korean Med Sci (2012) 0.77
Polyphenol (-)-epigallocatechin gallate-induced cardioprotection may attenuate ischemia-reperfusion injury through adenosine receptor activation: a preliminary study. Korean J Anesthesiol (2012) 0.75
Cardiodynamics and infarct size in regional and global ischemic isolated heart model: comparison of 1 hour and 2 hours reperfusion. Korean Circ J (2012) 0.75
Effects of postconditioning with N,N,N'N'-tetrakis-[2-pyridylmethyl]-ethylenediamine in isolated rat hearts. Korean J Anesthesiol (2010) 0.75
Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA (2006) 4.08
Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr (2003) 3.75
Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. Circ Res (1997) 3.41
Role of the mitochondrial permeability transition in myocardial disease. Circ Res (2003) 3.26
Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res (2002) 2.84
Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin Cancer Res (2005) 2.07
Postconditioning prevents reperfusion injury by activating delta-opioid receptors. Anesthesiology (2008) 1.71
Role of intracellular Na+ in Ca2+ overload and depressed recovery of ventricular function of reperfused ischemic rat hearts. Possible involvement of H+-Na+ and Na+-Ca2+ exchange. Circ Res (1989) 1.57
Myocardial K(ATP) channels in preconditioning. Circ Res (2000) 1.56
Mitochondrial ATP-sensitive K+ channels modulate cardiac mitochondrial function. Am J Physiol (1998) 1.42
PI 3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning. Cardiovasc Res (2005) 1.34
Mechanisms of Ca2+ overload in reperfused ischemic myocardium. Annu Rev Physiol (1990) 1.33
Epigallocatechin-3-gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia/reperfusion-induced apoptosis. FASEB J (2004) 1.31
Preconditioning limits mitochondrial Ca(2+) during ischemia in rat hearts: role of K(ATP) channels. Am J Physiol Heart Circ Physiol (2001) 1.17
The role of mitochondria in ischemic heart disease. J Cardiovasc Pharmacol (1996) 1.13
Epigallocatechin, a green tea polyphenol, attenuates myocardial ischemia reperfusion injury in rats. Mol Med (2004) 1.12
Inhibition of mitochondrial permeability transition enhances isoflurane-induced cardioprotection during early reperfusion: the role of mitochondrial KATP channels. Anesth Analg (2005) 1.10
B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart. Basic Res Cardiol (2007) 1.06
Ischemic preconditioning: infarct size is a more reliable endpoint than functional recovery. Basic Res Cardiol (2003) 1.05
Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity. J Pharmacol Exp Ther (2001) 0.99
Intracellular free calcium and mitochondrial membrane potential in ischemia/reperfusion and preconditioning. J Mol Cell Cardiol (2000) 0.95
Desflurane-induced preconditioning alters calcium-induced mitochondrial permeability transition. Anesthesiology (2004) 0.95
Effects of green tea intake on the development of coronary artery disease. Circ J (2004) 0.94
Contractile dysfunction and abnormal Ca2+ modulation during postischemic reperfusion in rat heart. Am J Physiol (1995) 0.90
Mitochondria are targets for geranylgeranylacetone-induced cardioprotection against ischemia-reperfusion in the rat heart. Am J Physiol Heart Circ Physiol (2007) 0.89
Role of increased cytosolic free calcium concentration in myocardial ischemic injury. Basic Res Cardiol (1994) 0.89
Inhibitory modulation of ATP-sensitive potassium channels by gallate-ester moiety of (-)-epigallocatechin-3-gallate. Biochem Pharmacol (2005) 0.85
Sevoflurane preconditioning limits intracellular/mitochondrial Ca2+ in ischemic newborn myocardium. Anesth Analg (2005) 0.84
Uncoupling by (--)-epigallocatechin-3-gallate of ATP-sensitive potassium channels from phosphatidylinositol polyphosphates and ATP. Pharmacol Res (2007) 0.83
Exogenous zinc protects cardiac cells from reperfusion injury by targeting mitochondrial permeability transition pore through inactivation of glycogen synthase kinase-3beta. Am J Physiol Heart Circ Physiol (2008) 1.73
Postconditioning prevents reperfusion injury by activating delta-opioid receptors. Anesthesiology (2008) 1.71
Pressure-wire based assessment of microvascular resistance using calibrated upstream balloon obstruction: a predictor of myocardial viability. Catheter Cardiovasc Interv (2011) 1.49
CHIP, a cochaperone/ubiquitin ligase that regulates protein quality control, is required for maximal cardioprotection after myocardial infarction in mice. Am J Physiol Heart Circ Physiol (2005) 1.43
Bradykinin prevents reperfusion injury by targeting mitochondrial permeability transition pore through glycogen synthase kinase 3beta. J Mol Cell Cardiol (2006) 1.42
Adenosine A2A and A2B receptors work in concert to induce a strong protection against reperfusion injury in rat hearts. J Mol Cell Cardiol (2009) 1.21
Comparison of triple versus dual antiplatelet therapy after drug-eluting stent implantation (from the DECLARE-Long trial). Am J Cardiol (2007) 1.20
N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta. J Pharmacol Exp Ther (2006) 1.19
Left-sided accessory pathway with ostial atresia of the coronary sinus: a case report. Pacing Clin Electrophysiol (2008) 1.11
Sirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease. Circulation (2006) 1.06
Molecular mechanism underlying Akt activation in zinc-induced cardioprotection. Am J Physiol Heart Circ Physiol (2009) 1.02
Incidence and predictors of drug-eluting stent fractures in long coronary disease. Int J Cardiol (2008) 1.00
Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore. Eur J Pharmacol (2008) 0.96
NO mobilizes intracellular Zn2+ via cGMP/PKG signaling pathway and prevents mitochondrial oxidant damage in cardiomyocytes. Cardiovasc Res (2007) 0.96
Congenital giant right coronary artery aneurysm with fistula to the coronary sinus and persistent left superior vena cava in an old woman. Korean Circ J (2012) 0.90
Morphine prevents the mitochondrial permeability transition pore opening through NO/cGMP/PKG/Zn2+/GSK-3beta signal pathway in cardiomyocytes. Am J Physiol Heart Circ Physiol (2009) 0.90
Life-threatening cardiac tamponade: a rare complication of acupuncture. J Cardiothorac Surg (2014) 0.90
Evidence for an intracellular localization of the adenosine A2B receptor in rat cardiomyocytes. Basic Res Cardiol (2011) 0.90
Comparison of 5 different remifentanil strategies against myocardial ischemia-reperfusion injury. J Cardiothorac Vasc Anesth (2011) 0.89
Ethanol prevents oxidant-induced mitochondrial permeability transition pore opening in cardiac cells. Alcohol Alcohol (2008) 0.89
Comparison of Triple antiplatelet therapy and dual antiplatelet therapy in patients at high risk of restenosis after drug-eluting stent implantation (from the DECLARE-DIABETES and -LONG Trials). Am J Cardiol (2009) 0.87
The molecular mechanism underlying morphine-induced Akt activation: roles of protein phosphatases and reactive oxygen species. Cell Biochem Biophys (2011) 0.86
Right ventricular wall hematoma secondary to percutaneous coronary intervention. J Cardiovasc Ultrasound (2009) 0.86
Effect of intra-coronary nicorandil administration prior to reperfusion in acute ST segment elevation myocardial infarction. Circ J (2008) 0.86
A randomized comparison of sirolimus- versus Paclitaxel-eluting stent implantation in patients with diabetes mellitus. J Am Coll Cardiol (2008) 0.85
Temporal changes and histologic relation of postsystolic thickening in an animal model of acute ischemia and reperfusion. J Am Soc Echocardiogr (2003) 0.84
Role of autophagy in myocardial reperfusion injury. Front Biosci (Elite Ed) (2010) 0.82
A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus: 4-year clinical outcomes of DES-DIABETES (drug-eluting stent in patients with DIABETES mellitus) trial. JACC Cardiovasc Interv (2011) 0.82
Incidence of and risk factors for bundle branch block in adults older than 40 years. Korean J Intern Med (2004) 0.81
Polyphenol (-)-epigallocatechin gallate targeting myocardial reperfusion limits infarct size and improves cardiac function. Korean J Anesthesiol (2010) 0.81
Effects of trimetazidine in patients with acute myocardial infarction: data from the Korean Acute Myocardial Infarction Registry. Clin Res Cardiol (2013) 0.81
MuRF1 activity is present in cardiac mitochondria and regulates reactive oxygen species production in vivo. J Bioenerg Biomembr (2014) 0.80
Influence of coronary collateral flow on restenosis following primary angioplasty for acute myocardial infarction. Catheter Cardiovasc Interv (2002) 0.80
NecroX-5 suppresses sodium nitroprusside-induced cardiac cell death through inhibition of JNK and caspase-3 activation. Cell Biol Int (2014) 0.80
Cardioprotection against reperfusion injury: updated mechanisms and strategies. Sheng Li Xue Bao (2007) 0.80
Step-and-shoot prospectively ECG-gated vs. retrospectively ECG-gated with tube current modulation coronary CT angiography using 128-slice MDCT patients with chest pain: diagnostic performance and radiation dose. Acta Radiol (2011) 0.79
Stromal cell derived factor-1 (SDF-1) targeting reperfusion reduces myocardial infarction in isolated rat hearts. Cardiovasc Ther (2011) 0.79
Astragaloside IV inhibits oxidative stress-induced mitochondrial permeability transition pore opening by inactivating GSK-3β via nitric oxide in H9c2 cardiac cells. Oxid Med Cell Longev (2012) 0.79
Catheter ablation of a left free-wall accessory pathway via the radial artery approach. Yonsei Med J (2007) 0.79
A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus 2-year clinical outcomes of the DES-DIABETES trial. J Am Coll Cardiol (2009) 0.79
Imaging of reactive oxygen species burst from mitochondria using laser scanning confocal microscopy. Microsc Res Tech (2013) 0.79
The critical role of intracellular zinc in adenosine A(2) receptor activation induced cardioprotection against reperfusion injury. J Mol Cell Cardiol (2010) 0.79
Porphyromonas gingivalis HSP60 peptides have distinct roles in the development of atherosclerosis. Mol Immunol (2015) 0.79
Mitral loop cerclage as a variant form of mitral cerclage annuloplasty that adds a device (CSTV) for preventing potential complications: a preclinical proof of concept and feasibility study. EuroIntervention (2016) 0.78
Prediction of Fractional Flow Reserve without Hyperemic Induction Based on Resting Baseline Pd/Pa. Korean Circ J (2013) 0.78
Ischemia-modified albumin (IMA) is not useful for detecting myocardial ischemia during symptom-limited exercise stress tests. Korean J Intern Med (2008) 0.78
Chlamydia pneumoniae infection promotes vascular smooth muscle cell migration through a Toll-like receptor 2-related signaling pathway. Infect Immun (2013) 0.78
Severe aortic coarctation in a 75-year-old woman: total simultaneous repair of aortic coarctation and severe aortic stenosis. Korean Circ J (2012) 0.78
Atrial natriuretic peptide prevents the mitochondrial permeability transition pore opening by inactivating glycogen synthase kinase 3β via PKG and PI3K in cardiac H9c2 cells. Eur J Pharmacol (2012) 0.78
Successful revascularization of coronary artery occluded by massive intracoronary thrombi with alteplase and percutaneous coronary intervention. J Atheroscler Thromb (2010) 0.77
Propyl paraben inhibits voltage-dependent sodium channels and protects cardiomyocytes from ischemia-reperfusion injury. Life Sci (2004) 0.76
Inhibition of phosphodiesterases leads to prevention of the mitochondrial permeability transition pore opening and reperfusion injury in cardiac H9c2 cells. Cardiovasc Drugs Ther (2011) 0.76
Characteristic findings of coronary artery disease in Kawasaki disease. J Am Coll Cardiol (2011) 0.76
Kobophenol A inhibits sodium nitroprusside-induced cardiac H9c2 cell death through suppressing activation of JNK and preserving mitochondrial anti-apoptotic Bcl-2 and Mcl-1. Chem Pharm Bull (Tokyo) (2014) 0.76
Assessment of left ventricular function and volume in patients undergoing 128-slice coronary CT angiography with ECG-based maximum tube current modulation: a comparison with echocardiography. Korean J Radiol (2011) 0.76
Catheter ablation of parahisian premature ventricular complex. Korean Circ J (2011) 0.75
Cardiodynamics and infarct size in regional and global ischemic isolated heart model: comparison of 1 hour and 2 hours reperfusion. Korean Circ J (2012) 0.75
Polyphenol (-)-epigallocatechin gallate-induced cardioprotection may attenuate ischemia-reperfusion injury through adenosine receptor activation: a preliminary study. Korean J Anesthesiol (2012) 0.75
Engorged serpentine veins across pacemaker scar. Korean Circ J (2011) 0.75
Bubbles in a row: finding of pulmonary arteriovenous fistula on transesophageal echocardiography. J Cardiovasc Ultrasound (2013) 0.75
Efficacy of cilostazol on uncontrolled coronary vasospastic angina: a pilot study. Cardiovasc Ther (2013) 0.75
Cardioprotection by kappa-opioid receptor agonist U50488H is mediated by opioidergic regulation but not by calcium current modulation. Korean J Anesthesiol (2010) 0.75
Eclipse of the heart: the echocardiographic finding of endomyocardial calcification. Acta Cardiol (2014) 0.75
Erratum to: MuRF1 activity is present in cardiac mitochondria and regulates reactive oxygen species production in vivo. J Bioenerg Biomembr (2015) 0.75
Radiation reduction during percutaneous coronary intervention: A new protocol with a low frame rate and selective fluoroscopic image storage. Medicine (Baltimore) (2017) 0.75
Intractable hemolytic anemia after mitral valve repair: a report of three cases. Echocardiography (2013) 0.75
Severe mitral stenosis secondary to Hunter's syndrome. Circulation (2013) 0.75
High-definition computed tomography for coronary artery stents: image quality and radiation doses for low voltage (100 kVp) and standard voltage (120 kVp) ECG-triggered scanning. Int J Cardiovasc Imaging (2015) 0.75
Drug-eluting stenting of unprotected left main coronary artery stenosis in patients with orthotopic heart transplantation: Initial clinical experience. Catheter Cardiovasc Interv (2008) 0.75
Safety of tirofiban therapy in korean patients with acute coronary syndrome. Circ J (2005) 0.75
A doughnut in the heart: peculiar finding of a giant coronary artery aneurysm with coronary arteriovenous fistula. J Am Coll Cardiol (2010) 0.75
Hail in silence! Mobile thrombus in the aortic arch. Circulation (2010) 0.75
The impact of transferring patients with ST-segment elevation myocardial infarction to percutaneous coronary intervention-capable hospitals on clinical outcomes. Cardiol J (2016) 0.75